Celmatix is dedicated to advancing women’s health by leveraging all available innovations in technology with data and genomics. Our research-based products help clinics optimize patient outcomes and improve the patient experience. The Fertilome test is the world’s first multi-gene genetic screen that reveals what a woman's DNA says about her reproductive health and fertility potential. This next generation sequencing panel reveals factors that are associated with the most common reproductive conditions in women. By revealing genetic risk factors, the Fertilome test enables more refined diagnoses and treatment decisions than physical examinations or existing diagnostic tests alone. Using the genetic test can help you frame conversations around reproductive health and family building as a proactive journey.